Q4 2022 Voyager Therapeutics Inc Earnings Call Transcript
Good morning, and welcome to Voyager Therapeutics 2022 Fourth Quarter and Year-End Conference Call. (Operator Instructions) Please be advised this call is being recorded at the company's request. (Operator Instructions)
I would now like turn the call over to Pete Pfreundschuh, Chief Financial Officer.
Thank you, and Good morning. Joining me on today's call are Dr. Al Sandrock, our CEO; Dr. Todd Carter, our Chief Scientific Officer; and Allen Nunnally, our Chief Business Officer.
We issued our Q4 and Year-End 2022 press release this morning. The press release and 10-K are available on our website. We plan to provide a brief summary of key highlights from the quarter and reserve the majority of time for your Q&A.
In a moment, I will turn the call over to Al. Before I do this, I want to remind everyone that during this call, Voyager representatives may make forward-looking statements regarding future expectations, plans and prospects. All forward-looking statements are
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
